Sign in

CIK 0001867096

  • Large accelerated filer

Xeris Biopharma Holdings, Inc.

Sign in to watch
Ticker
XERS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
871082097
Phone
+1 844-445-5704
Business address
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
  1. 4 Grant or award Pieper Steven acquired 200,000 shares (grant or award)
  2. 4 Grant or award JOHNSON KENNETH ERLAND acquired 75,000 shares (grant or award)
  3. 4 Grant or award Hecht Beth acquired 225,000 shares (grant or award)
  4. 4 Grant or award Shannon John Patrick Jr acquired 250,000 shares (grant or award)
  5. 4 Grant or award Edick Paul R acquired 600,000 shares (grant or award)
  6. 4 Grant or award Chief Scientific Officer acquired 75,000 shares (grant or award)
  7. 4 Open-market buy Edick Paul R bought 20,000 shares at $2.28 ($45,664)
  8. 4 Open-market buy Shannon John Patrick Jr bought 100,000 shares at an average $2.10 ($209,500)
  9. 4 Open-market buy Edick Paul R bought 200,000 shares at $2.08 ($415,760)
  10. 4 Open-market buy Pieper Steven bought 25,000 shares at $2.00 ($49,918)
  11. 4/A Grant or award Director acquired 50,170 shares (grant or award)
  12. 4/A Grant or award Director acquired 478,312 shares (grant or award)
  13. 4 Grant or award Director acquired 50,170 shares (grant or award)
  14. 4 Grant or award Director acquired 478,312 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Grant or award Edick Paul R acquired 621,494 shares (grant or award)
  18. 4 Grant or award Shannon John Patrick Jr acquired 263,829 shares (grant or award)
  19. 4 Grant or award Chief Scientific Officer acquired 494,780 shares (grant or award)
  20. 4 Derivatives Options or other derivatives

Page 8 of 9 · 178 filings